| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |